ARCHIVES

Pooled Analysis of Two LUX-Lung Trials Shows Prolonged Survival with Afatinib

This article is from The Cancer Letter archive.

Vol. 37 No. 6 | June 27, 2014

Download PDF Visit The Full Archive

Related Articles

It’s “High Noon” For Cancer, Vice President Says

October 2, 1998

Cancer Meetings Listed For May and June

April 23, 1993

In Brief: MSK Opens Laurence Rockefeller Pavilion; Bush Event raised 410 Million for Anderson

July 9, 1999

FDA advisors vote against recommending Johnson & Johnson’s Zarnestra for treatment of AML in the elderly.

May 6, 2005

ONS Accredited As Approver, Provider Of Continuing Education

April 22, 1988

Decision On New Division Two-Three Weeks Away: Upton

August 17, 1979